Medtronic plc.

Open: 85.33 Close: 85.67 Change: 0.34

Are you still looking for information about Medtronic plc. Company Inc Stock? An AI summarized it for you.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, business, Monitoring, market, Care, year, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC closed $6.96 short of its 52-week high ($92.02) The medical device company underperforms when compared to competitors - underperformantly compared to market competitors - when compared.

Today's News

Medtronic is projected to report quarterly revenue of $7.95 billion, according to data from Benzinga Pro. Medtronic used approximately 414,300 megawatt hours (MWh) of renewable electricity last year, accounting for more than 46% of their total electricity usage. The medical device company underperforms when compared to competitors - underperformantly compared to market competitors - when compared. Medtronic PLC closed $6.96 short of its 52-week high ($92.02), which the company achieved on May 3rd.02. Shares of the company inched 0.72% higher to $85.67 on what proved to be an all-around great trading session for the stock market. Medtronic Nixes Spinoff Plans For Monitoring And Respiratory Units. Medtronics will retain PMRI business which forms part of Medical Surgical Portfolio, while its unprofitable Ventilator business would be discontinued. The intrinsic value of one MDT stock under the Base Case scenario is 94.34 USD. Compared to the current market price of 85.67 USD , Medtronic PLCis Undervalued by 9%. Medtronic is in the Health Care sector and Health Care Equipment & Supplies industry. The company is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 23, 2024. Medtronic PLC reports results for the quarter ended in January, identical to the same quarter last year. The company expects full-year earnings in the range of $5.19 to $5.21 per share. Medtronic has called it quits on the ventilator market, citing “increasingly unprofitable” product lines. The remaining businesses in the companys Patient Monitoring and Respiratory Interventions (PMRI) unit will combine to form a new Acute Care and Monitoring business. Medtronic CEO Geoff Martha announced that White was leaving at the end of the companys Q3 earnings call this morning. Martha also explained plans to end Medtronics ventilator business and combine what remains of the Patient Monitoring and Respiratory Interventions operating units into one business unit called Acute Care & Monitoring. The medical device leader announced strong quarterly results and raised its full-year outlook. Medtronic: Fiscal Q3 Earnings Snapshot: 85.67 (+0.72%) WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, business, Monitoring, market, Care, year, and the most common words in the summary are: medtronic, stock, market, best, mdt, news, plc, . One of the sentences in the summary was: Medtronic PLC closed $6.96 short of its 52-week high ($92.02) The medical device company underperforms when compared to competitors - underperformantly compared to market competitors - when compared.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #best #mdt #news #plc.